Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 137

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

The regulatory roles of p53 in cardiovascular health and disease

Men, Hongbo, Cai, He, Cheng, Quanli, Zhou, Wenqian, Wang, Xiang, Huang, Shan, Zheng, Yang, Cai, Lu · 2021 · Cellular and Molecular Life Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-020-03694-6

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 145

  1. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington’s disease. Neuron 47(1):29–41. https://doi.org/10.1016/j.neuron.2005.06.005 · DOI · Paper page
  2. Bretaud S, Allen C, Ingham PW, Bandmann O (2007) p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s disease. J Neurochem 100(6):1626–1635. https://doi.org/10.1111/j.1471-4159.2006.04291.x · DOI · Paper page
  3. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331(3):761–777. https://doi.org/10.1016/j.bbrc.2005.03.149 · DOI · Paper page
  4. Duan W, Zhu X, Ladenheim B, Yu QS, Guo Z, Oyler J, Cutler RG, Cadet JL, Greig NH, Mattson MP (2002) p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann Neurol 52(5):597–606. https://doi.org/10.1002/ana.10350 · DOI · Paper page
  5. Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, McKenzie AN (2010) A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 16(1):59–66. https://doi.org/10.1038/nm.2063 · DOI · Paper page
  6. Jones NC, Lynn ML, Gaudenz K, Sakai D, Aoto K, Rey JP, Glynn EF, Ellington L, Du C, Dixon J, Dixon MJ, Trainor PA (2008) Prevention of the neurocristopathy treacher collins syndrome through inhibition of p53 function. Nat Med 14(2):125–133. https://doi.org/10.1038/nm1725 · DOI · Paper page
  7. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ, Zhang W, Fuchs H, de Angelis MH, Myers RM, Attardi LD, Barsh GS (2008) Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40(8):963–970. https://doi.org/10.1038/ng.188 · DOI · Paper page
  8. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kajstura J, Hintze TH, Anversa P (1998) Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97(2):194–203. https://doi.org/10.1161/01.cir.97.2.194 · DOI
  9. Song H, Conte JV Jr, Foster AH, McLaughlin JS, Wei C (1999) Increased p53 protein expression in human failing myocardium. J Heart Lung Trans 18(8):744–749. https://doi.org/10.1016/s1053-2498(98)00039-4 · DOI
  10. Zhang Q, He X, Chen L, Zhang C, Gao X, Yang Z, Liu G (2012) Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development. J Pathol 228(3):416–428. https://doi.org/10.1002/path.4077 · DOI
  11. Mak TW, Hauck L, Grothe D, Billia F (2017) p53 regulates the cardiac transcriptome. Proc Natl Acad Sci USA 114(9):2331–2336. https://doi.org/10.1073/pnas.1621436114 · DOI · Paper page
  12. Chatterjee A, Mir SA, Dutta D, Mitra A, Pathak K, Sarkar S (2011) Analysis of p53 and NF-kappaB signaling in modulating the cardiomyocyte fate during hypertrophy. J Cell Physiol 226(10):2543–2554. https://doi.org/10.1002/jcp.22599 · DOI
  13. Nakamura H, Matoba S, Iwai-Kanai E, Kimata M, Hoshino A, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, Ikeda K, Okigaki M, Adachi S, Tanaka H, Takamatsu T, Matsubara H (2012) p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation. Circ Heart Fail 5(1):106–115. https://doi.org/10.1161/CIRCHEARTFAILURE.111.961565 · DOI · Paper page
  14. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR (2005) Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 96(6):667–674. https://doi.org/10.1161/01.RES.0000161069.15577.ca · DOI · Paper page
  15. Xu T, Ding W, Ao X, Chu X, Wan Q, Wang Y, Xiao D, Yu W, Li M, Yu F, Wang J (2019) ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening. Redox Biol 20:414–426. https://doi.org/10.1016/j.redox.2018.10.023 · DOI · Paper page
  16. Collaborators GBDCHD (2020) Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health 4(3):185–200. https://doi.org/10.1016/S2352-4642(19)30402-X · DOI · Paper page
  17. Moreau JLM, Kesteven S, Martin E, Lau KS, Yam MX, O’Reilly VC, Del Monte-Nieto G, Baldini A, Feneley MP, Moon AM, Harvey RP, Sparrow DB, Chapman G, Dunwoodie SL (2019) Gene-environment interaction impacts on heart development and embryo survival. Development. https://doi.org/10.1242/dev.172957 · DOI
  18. Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, Lin CY, Lin CJ, Swiderski DL, Vogel H, Bernstein JA, Attie-Bitach T, Chang CP, Wysocka J, Martin DM, Attardi LD (2014) Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature 514(7521):228–232. https://doi.org/10.1038/nature13585 · DOI · Paper page
  19. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79. https://doi.org/10.1146/annurev.physiol.65.092101.142243 · DOI · Paper page
  20. Nomura S, Satoh M, Fujita T, Higo T, Sumida T, Ko T, Yamaguchi T, Tobita T, Naito AT, Ito M, Fujita K, Harada M, Toko H, Kobayashi Y, Ito K, Takimoto E, Akazawa H, Morita H, Aburatani H, Komuro I (2018) Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat Commun 9(1):4435. https://doi.org/10.1038/s41467-018-06639-7 · DOI · Paper page
  21. Sheng R, Gu ZL, Xie ML, Zhou WX, Guo CY (2007) EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats. Acta Pharmacol Sin 28(2):191–201. https://doi.org/10.1111/j.1745-7254.2007.00495.x · DOI
  22. Frangogiannis NG (2015) Pathophysiology of Myocardial Infarction. Compr Physiol 5(4):1841–1875. https://doi.org/10.1002/cphy.c150006 · DOI · Paper page
  23. Liu CY, Zhang YH, Li RB, Zhou LY, An T, Zhang RC, Zhai M, Huang Y, Yan KW, Dong YH, Ponnusamy M, Shan C, Xu S, Wang Q, Zhang YH, Zhang J, Wang K (2018) LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun 9(1):29. https://doi.org/10.1038/s41467-017-02280-y · DOI · Paper page
  24. Gogna R, Madan E, Khan M, Pati U, Kuppusamy P (2013) p53’s choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. EMBO Mol Med 5(11):1662–1683. https://doi.org/10.1002/emmm.201202055 · DOI · Paper page
  25. Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. https://doi.org/10.1038/s41569-020-0339-2 · DOI · Paper page
  26. Dillmann WH (2019) Diabetic cardiomyopathy. Circ Res 124(8):1160–1162. https://doi.org/10.1161/CIRCRESAHA.118.314665 · DOI · Paper page
  27. Gu J, Wang S, Guo H, Tan Y, Liang Y, Feng A, Liu Q, Damodaran C, Zhang Z, Keller BB, Zhang C, Cai L (2018) Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis. Cell Death Dis 9(2):82. https://doi.org/10.1038/s41419-017-0093-5 · DOI · Paper page
  28. Liu X, Chua CC, Gao J, Chen Z, Landy CL, Hamdy R, Chua BH (2004) Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286(3):H933-939. https://doi.org/10.1152/ajpheart.00759.2003 · DOI · Paper page
  29. Renu K, V GA, P BT, Arunachalam S, (2018) Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Eur J Pharmacol 818:241–253. https://doi.org/10.1016/j.ejphar.2017.10.043 · DOI · Paper page
  30. Li J, Wang PY, Long NA, Zhuang J, Springer DA, Zou J, Lin Y, Bleck CKE, Park JH, Kang JG, Hwang PM (2019) p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Proc Natl Acad Sci USA 116(39):19626–19634. https://doi.org/10.1073/pnas.1904979116 · DOI
  31. Saleme B, Gurtu V, Zhang Y, Kinnaird A, Boukouris AE, Gopal K, Ussher JR, Sutendra G (2019) Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aau8866 · DOI
  32. Ihling C, Haendeler J, Menzel G, Hess RD, Fraedrich G, Schaefer HE, Zeiher AM (1998) Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol 185(3):303–312. https://doi.org/10.1002/(SICI)1096-9896(199807)185:3%3c303::AID-PATH106%3e3.0.CO;2-P · DOI · Paper page
  33. Birks EJ, Latif N, Enesa K, Folkvang T, le Luong A, Sarathchandra P, Khan M, Ovaa H, Terracciano CM, Barton PJ, Yacoub MH, Evans PC (2008) Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res 79(3):472–480. https://doi.org/10.1093/cvr/cvn083 · DOI · Paper page
  34. Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM (2010) Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121(8):997–1004. https://doi.org/10.1161/CIRCULATIONAHA.109.904557 · DOI · Paper page
  35. Eble DM, Spragia ML, Ferguson AG, Samarel AM (1999) Sarcomeric myosin heavy chain is degraded by the proteasome. Cell Tissue Res 296(3):541–548. https://doi.org/10.1007/s004410051315 · DOI
  36. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C (2004) Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114(8):1058–1071. https://doi.org/10.1172/JCI22220 · doi:10.1172/jci22220 · Paper page
  37. Tsukamoto O, Minamino T, Okada K, Shintani Y, Takashima S, Kato H, Liao Y, Okazaki H, Asai M, Hirata A, Fujita M, Asano Y, Yamazaki S, Asanuma H, Hori M, Kitakaze M (2006) Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 340(4):1125–1133. https://doi.org/10.1016/j.bbrc.2005.12.120 · DOI
  38. Balasubramanian S, Mani S, Shiraishi H, Johnston RK, Yamane K, Willey CD, Gt Cooper, Tuxworth WJ, Kuppuswamy D (2006) Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases. J Mol Cell Cardiol 41(4):669–679. https://doi.org/10.1016/j.yjmcc.2006.04.022 · DOI
  39. Karni-Schmidt O, Lokshin M, Prives C (2016) The roles of MDM2 and MDMX in cancer. Annu Rev Pathol 11:617–644. https://doi.org/10.1146/annurev-pathol-012414-040349 · DOI · Paper page
  40. McDonough H, Patterson C (2003) CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8(4):303–308. https://doi.org/10.1379/1466-1268(2003)008%3c0303:calbtc%3e2.0.co;2 · DOI · Paper page
  41. Naito AT, Okada S, Minamino T, Iwanaga K, Liu ML, Sumida T, Nomura S, Sahara N, Mizoroki T, Takashima A, Akazawa H, Nagai T, Shiojima I, Komuro I (2010) Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res 106(11):1692–1702. https://doi.org/10.1161/CIRCRESAHA.109.214346 · DOI
  42. Heo KS, Lee H, Nigro P, Thomas T, Le NT, Chang E, McClain C, Reinhart-King CA, King MR, Berk BC, Fujiwara K, Woo CH, Abe J (2011) PKCzeta mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation. J Cell Biol 193(5):867–884. https://doi.org/10.1083/jcb.201010051 · DOI
  43. Chua CC, Liu X, Gao J, Hamdy RC, Chua BH (2006) Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol 290(6):H2606-2613. https://doi.org/10.1152/ajpheart.01138.2005 · DOI
  44. Zhou SF, Yuan J, Liao MY, Xia N, Tang TT, Li JJ, Jiao J, Dong WY, Nie SF, Zhu ZF, Zhang WC, Lv BJ, Xiao H, Wang Q, Tu X, Liao YH, Shi GP, Cheng X (2014) IL-17A promotes ventricular remodeling after myocardial infarction. J Mol Med (Berl) 92(10):1105–1116. https://doi.org/10.1007/s00109-014-1176-8 · DOI
  45. Su D, Guan L, Gao Q, Li Q, Shi C, Liu Y, Sun L, Lu C, Ma X (1863) Zhao J (2017) ROCK1/p53/NOXA signaling mediates cardiomyocyte apoptosis in response to high glucose in vitro and vivo. Biochim Biophys Acta Mol Basis Dis 4:936–946. https://doi.org/10.1016/j.bbadis.2017.01.021 · DOI · Paper page
  46. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50(10):2363–2375. https://doi.org/10.2337/diabetes.50.10.2363 · DOI · Paper page
  47. Vahtola E, Louhelainen M, Forsten H, Merasto S, Raivio J, Kaheinen P, Kyto V, Tikkanen I, Levijoki J, Mervaala E (2010) Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat. Cardiovasc Diabetol 9:5. https://doi.org/10.1186/1475-2840-9-5 · DOI · Paper page
  48. Mu W, Zhang Q, Tang X, Fu W, Zheng W, Lu Y, Li H, Wei Y, Li L, She Z, Chen H, Liu D (2014) Overexpression of a dominant-negative mutant of SIRT1 in mouse heart causes cardiomyocyte apoptosis and early-onset heart failure. Sci China Life Sci 57(9):915–924. https://doi.org/10.1007/s11427-014-4687-1 · DOI · Paper page
  49. Nagpal V, Rai R, Place AT, Murphy SB, Verma SK, Ghosh AK, Vaughan DE (2016) MiR-125b is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis. Circulation 133(3):291–301. https://doi.org/10.1161/CIRCULATIONAHA.115.018174 · DOI · Paper page
  50. Zhou Y, Richards AM, Wang P (2019) MicroRNA-221 Is cardioprotective and anti-fibrotic in a rat model of myocardial infarction. Mol Ther Nucleic Acids 17:185–197. https://doi.org/10.1016/j.omtn.2019.05.018 · DOI
  51. Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen C, Cai Y, Huang H, Yang Y, Liu Y, Xu Z, He D, Zhang X, Hu X, Pinello L, Zhong D, He F, Yuan GC, Wang DZ, Zeng C (2014) LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130(17):1452–1465. https://doi.org/10.1161/CIRCULATIONAHA.114.011675 · DOI · Paper page
  52. Fu BC, Lang JL, Zhang DY, Sun L, Chen W, Liu W, Liu KY, Ma CY, Jiang SL, Li RK, Tian H (2017) Suppression of miR-34a expression in the myocardium protects against ischemia-reperfusion injury through SIRT1 protective pathway. Stem Cells Dev 26(17):1270–1282. https://doi.org/10.1089/scd.2017.0062 · DOI
  53. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446(7134):444–448. https://doi.org/10.1038/nature05602 · DOI · Paper page
  54. Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301(6):H2181-2190. https://doi.org/10.1152/ajpheart.00554.2011 · DOI · Paper page
  55. Carr AM (2000) Cell cycle. Piecing together the p53 puzzle. Science 287(5459):1765–1766. https://doi.org/10.1126/science.287.5459.1765 · DOI
  56. Tanimoto K, Makino Y, Pereira T, Poellinger L (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19(16):4298–4309. https://doi.org/10.1093/emboj/19.16.4298 · DOI · Paper page
  57. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3):399–408. https://doi.org/10.1016/j.cell.2012.01.021 · DOI · Paper page
  58. Semenza GL (2014) Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol 76:39–56. https://doi.org/10.1146/annurev-physiol-021113-170322 · DOI · Paper page
  59. Joshi S, Singh AR, Durden DL (2014) MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem 289(33):22785–22797. https://doi.org/10.1074/jbc.M114.587493 · DOI
  60. Zhou CH, Zhang XP, Liu F, Wang W (2015) Modeling the interplay between the HIF-1 and p53 pathways in hypoxia. Sci Rep 5:13834. https://doi.org/10.1038/srep13834 · DOI
  61. Zou Y, Li J, Ma H, Jiang H, Yuan J, Gong H, Liang Y, Guan A, Wu J, Li L, Zhou N, Niu Y, Sun A, Nakai A, Wang P, Takano H, Komuro I, Ge J (2011) Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol 51(5):821–829. https://doi.org/10.1016/j.yjmcc.2011.07.030 · DOI
  62. Gogiraju R, Xu X, Bochenek ML, Steinbrecher JH, Lehnart SE, Wenzel P, Kessel M, Zeisberg EM, Dobbelstein M, Schafer K (2015) Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Am Heart Assoc. https://doi.org/10.1161/JAHA.115.001770 · DOI
  63. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111(16):2073–2085. https://doi.org/10.1161/01.CIR.0000162472.52990.36 · DOI · Paper page
  64. Guo J, Mihic A, Wu J, Zhang Y, Singh K, Dhingra S, Weisel RD, Li RK (2015) Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy. Eur Heart J 36(37):2530–2540. https://doi.org/10.1093/eurheartj/ehv294 · DOI
  65. Augustyn KE, Merino EJ, Barton JK (2007) A role for DNA-mediated charge transport in regulating p53: oxidation of the DNA-bound protein from a distance. Proc Natl Acad Sci USA 104(48):18907–18912. https://doi.org/10.1073/pnas.0709326104 · DOI
  66. Yoshida M, Shiojima I, Ikeda H, Komuro I (2009) Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 47(5):698–705. https://doi.org/10.1016/j.yjmcc.2009.07.024 · DOI · Paper page
  67. Liu B, Chen Y, St Clair DK (2008) ROS and p53: a versatile partnership. Free Radic Biol Med 44(8):1529–1535. https://doi.org/10.1016/j.freeradbiomed.2008.01.011 · DOI · Paper page
  68. Oskarsson HJ, Coppey L, Weiss RM, Li WG (2000) Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res 45(3):679–687. https://doi.org/10.1016/s0008-6363(99)00400-9 · DOI
  69. Dong Y, Chen H, Gao J, Liu Y, Li J, Wang J (2019) Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol 136:27–41. https://doi.org/10.1016/j.yjmcc.2019.09.001 · DOI · Paper page
  70. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292(5517):727–730. https://doi.org/10.1126/science.1059108 · DOI · Paper page
  71. Mandl A, Huong Pham L, Toth K, Zambetti G, Erhardt P (2011) Puma deletion delays cardiac dysfunction in murine heart failure models through attenuation of apoptosis. Circulation 124(1):31–39. https://doi.org/10.1161/CIRCULATIONAHA.110.988303 · DOI
  72. Mantawy EM, Esmat A, El-Bakly WM, Salah ElDin RA, El-Demerdash E (2017) Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: plausible roles of p53 MAPK and AKT pathways. Sci Rep 7(1):4795. https://doi.org/10.1038/s41598-017-05005-9 · DOI
  73. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23(16):2861–2874. https://doi.org/10.1038/sj.onc.1207523 · DOI · Paper page
  74. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23(10):2134–2145. https://doi.org/10.1038/sj.emboj.7600210 · DOI · Paper page
  75. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, Penninger JM (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410(6828):549–554. https://doi.org/10.1038/35069004 · DOI · Paper page
  76. Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29(Pt 6):684–688. https://doi.org/10.1042/0300-5127:0290684 · DOI · Paper page
  77. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub V, Tobar A, Vidne BA (2003) Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284(6):H2351-2359. https://doi.org/10.1152/ajpheart.00783.2002 · DOI · Paper page
  78. Liu J, Ai Y, Niu X, Shang F, Li Z, Liu H, Li W, Ma W, Chen R, Wei T, Li X, Li X (2020) Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation. Chem Biol Interact 317:108972. https://doi.org/10.1016/j.cbi.2020.108972 · DOI
  79. Chen Q, Thompson J, Hu Y, Das A, Lesnefsky EJ (2019) Cardiac specific knockout of p53 decreases ER stress-induced mitochondrial damage. Front Cardiovasc Med 6:10. https://doi.org/10.3389/fcvm.2019.00010 · DOI
  80. Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF, Allen J, Hersey P, Zhang XD (2008) Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 68(16):6708–6717. https://doi.org/10.1158/0008-5472.CAN-08-0349 · DOI
  81. Lin WC, Chuang YC, Chang YS, Lai MD, Teng YN, Su IJ, Wang CC, Lee KH, Hung JH (2012) Endoplasmic reticulum stress stimulates p53 expression through NF-kappaB activation. PLoS One 7(7):e39120. https://doi.org/10.1371/journal.pone.0039120 · DOI
  82. Li J, Lee B, Lee AS (2006) Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 281(11):7260–7270. https://doi.org/10.1074/jbc.M509868200 · DOI · Paper page
  83. Zhang F, Hamanaka RB, Bobrovnikova-Marjon E, Gordan JD, Dai MS, Lu H, Simon MC, Diehl JA (2006) Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem 281(40):30036–30045. https://doi.org/10.1074/jbc.M604674200 · DOI
  84. Giorgi C, Bonora M, Sorrentino G, Missiroli S, Poletti F, Suski JM, Galindo Ramirez F, Rizzuto R, Di Virgilio F, Zito E, Pandolfi PP, Wieckowski MR, Mammano F, Del Sal G, Pinton P (2015) p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc Natl Acad Sci USA 112(6):1779–1784. https://doi.org/10.1073/pnas.1410723112 · DOI · Paper page
  85. Fusee LTS, Marin M, Fahraeus R, Lopez I (2020) Alternative mechanisms of p53 action during the unfolded protein response. Cancers (Basel). https://doi.org/10.3390/cancers12020401 · DOI
  86. Ji L, Roth JA (2008) Tumor suppressor FUS1 signaling pathway. J Thorac Oncol 3(4):327–330. https://doi.org/10.1097/JTO.0b013e31816bce65 · DOI
  87. Wu H, Zhao ZA, Liu J, Hao K, Yu Y, Han X, Li J, Wang Y, Lei W, Dong N, Shen Z, Hu S (2018) Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction. Gene Ther 25(8):511–523. https://doi.org/10.1038/s41434-018-0045-4 · DOI
  88. Singh R, Chaudhary P, Arya R (2018) Role of IGF-1R in ameliorating apoptosis of GNE deficient cells. Sci Rep 8(1):7323. https://doi.org/10.1038/s41598-018-25510-9 · DOI
  89. Yu XY, Geng YJ, Liang JL, Lin QX, Lin SG, Zhang S, Li Y (2010) High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res 316(17):2903–2909. https://doi.org/10.1016/j.yexcr.2010.07.004 · DOI
  90. Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME, Karnezis AN, Attardi LD (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145(4):571–583. https://doi.org/10.1016/j.cell.2011.03.035 · DOI · Paper page
  91. Ai TJ, Sun JY, Du LJ, Shi C, Li C, Sun XN, Liu Y, Li L, Xia Z, Jia L, Liu J, Duan SZ (2018) Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62. Cell Death Differ 25(2):319–329. https://doi.org/10.1038/cdd.2017.160 · DOI
  92. Choi AM, Ryter SW, Levine B (2013) Autophagy in human health and disease. N Engl J Med 368(7):651–662. https://doi.org/10.1056/NEJMra1205406 · DOI · Paper page
  93. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G (2010) Autophagy regulation by p53. Curr Opin Cell Biol 22(2):181–185. https://doi.org/10.1016/j.ceb.2009.12.001 · DOI · Paper page
  94. Wang EY, Gang H, Aviv Y, Dhingra R, Margulets V, Kirshenbaum LA (2013) p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension 62(1):70–77. https://doi.org/10.1161/HYPERTENSIONAHA.113.01028 · DOI
  95. Hoshino A, Matoba S, Iwai-Kanai E, Nakamura H, Kimata M, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, Ikeda K, Ueyama T, Okigaki M, Matsubara H (2012) p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol 52(1):175–184. https://doi.org/10.1016/j.yjmcc.2011.10.008 · DOI · Paper page
  96. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105(7):851–862. https://doi.org/10.1016/s0092-8674(01)00404-4 · DOI · Paper page
  97. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A (2012) Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125(25):3170–3181. https://doi.org/10.1161/CIRCULATIONAHA.111.041814 · DOI · Paper page
  98. Xiao C, Wang K, Xu Y, Hu H, Zhang N, Wang Y, Zhong Z, Zhao J, Li Q, Zhu D, Ke C, Zhong S, Wu X, Yu H, Zhu W, Chen J, Zhang J, Wang J, Hu X (2018) Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ Res 123(5):564–578. https://doi.org/10.1161/CIRCRESAHA.118.312758 · DOI · Paper page
  99. Edinger AL, Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16(6):663–669. https://doi.org/10.1016/j.ceb.2004.09.011 · DOI · Paper page
  100. Zhu H, Sun A (2018) Programmed necrosis in heart disease: Molecular mechanisms and clinical implications. J Mol Cell Cardiol 116:125–134. https://doi.org/10.1016/j.yjmcc.2018.01.018 · DOI
  101. Karch J, Molkentin JD (2014) Identifying the components of the elusive mitochondrial permeability transition pore. Proc Natl Acad Sci U S A 111(29):10396–10397. https://doi.org/10.1073/pnas.1410104111 · DOI
  102. Wang K, Liu F, Liu CY, An T, Zhang J, Zhou LY, Wang M, Dong YH, Li N, Gao JN, Zhao YF, Li PF (2016) The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ 23(8):1394–1405. https://doi.org/10.1038/cdd.2016.28 · DOI · Paper page
  103. Zhang XD, Qin ZH, Wang J (2010) The role of p53 in cell metabolism. Acta Pharmacol Sin 31(9):1208–1212. https://doi.org/10.1038/aps.2010.151 · DOI
  104. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED (2005) Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146(12):5341–5349. https://doi.org/10.1210/en.2005-0938 · DOI · Paper page
  105. Wang PY, Ma W, Park JY, Celi FS, Arena R, Choi JW, Ali QA, Tripodi DJ, Zhuang J, Lago CU, Strong LC, Talagala SL, Balaban RS, Kang JG, Hwang PM (2013) Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368(11):1027–1032. https://doi.org/10.1056/NEJMoa1214091 · DOI · Paper page
  106. Park JY, Wang PY, Matsumoto T, Sung HJ, Ma W, Choi JW, Anderson SA, Leary SC, Balaban RS, Kang JG, Hwang PM (2009) p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 105 (7):705-712, 711 p following 712. doi:https://doi.org/10.1161/CIRCRESAHA.109.205310 · DOI · Paper page
  107. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chretien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, Nakamura Y, Munnich A, Rotig A (2007) Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39(6):776–780. https://doi.org/10.1038/ng2040 · DOI · Paper page
  108. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, DiMauro S, Schon EA (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23(3):333–337. https://doi.org/10.1038/15513 · DOI · Paper page
  109. Xue W, Cai L, Tan Y, Thistlethwaite P, Kang YJ, Li X, Feng W (2010) Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice. Am J Pathol 177(1):97–105. https://doi.org/10.2353/ajpath.2010.091091 · DOI
  110. Schwartz D, Rotter V (1998) p53-dependent cell cycle control: response to genotoxic stress. Semin Cancer Biol 8(5):325–336. https://doi.org/10.1006/scbi.1998.0095 · DOI · Paper page
  111. Bohlig L, Rother K (2011) One function–multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol 2011:464916. https://doi.org/10.1155/2011/464916 · DOI
  112. Engeland K (2018) Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ 25(1):114–132. https://doi.org/10.1038/cdd.2017.172 · DOI · Paper page
  113. Brown MS, Goldstein JL (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223–261. https://doi.org/10.1146/annurev.bi.52.070183.001255 · DOI · Paper page
  114. Ihling C, Menzel G, Wellens E, Monting JS, Schaefer HE, Zeiher AM (1997) Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 17(10):2218–2224. https://doi.org/10.1161/01.atv.17.10.2218 · DOI
  115. Merched AJ, Williams E, Chan L (2003) Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol 23(9):1608–1614. https://doi.org/10.1161/01.ATV.0000084825.88022.53 · DOI
  116. Guevara NV, Kim HS, Antonova EI, Chan L (1999) The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 5(3):335–339. https://doi.org/10.1038/6585 · DOI · Paper page
  117. Song P, Xie Z, Wu Y, Xu J, Dong Y, Zou MH (2008) Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem 283(18):12446–12455. https://doi.org/10.1074/jbc.M708208200 · DOI
  118. Sun L, Dou F, Chen J, Chi H, Xing S, Liu T, Sun S, Chen C (2018) Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model. Mol Med Rep 17(1):257–263. https://doi.org/10.3892/mmr.2017.7872 · DOI
  119. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105(13):1541–1544. https://doi.org/10.1161/01.cir.0000013836.85741.17 · DOI · Paper page
  120. Fedele M, Benvenuto G, Pero R, Majello B, Battista S, Lembo F, Vollono E, Day PM, Santoro M, Lania L, Bruni CB, Fusco A, Chiariotti L (2000) A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem 275(11):7894–7901. https://doi.org/10.1074/jbc.275.11.7894 · DOI
  121. Le NT, Sandhu UG, Quintana-Quezada RA, Hoang NM, Fujiwara K, Abe JI (2017) Flow signaling and atherosclerosis. Cell Mol Life Sci 74(10):1835–1858. https://doi.org/10.1007/s00018-016-2442-4 · DOI
  122. Takabe W, Alberts-Grill N, Jo H (2011) Disturbed flow: p53 SUMOylation in the turnover of endothelial cells. J Cell Biol 193(5):805–807. https://doi.org/10.1083/jcb.201104140 · doi:10.1083/jcb.201104140
  123. Lin K, Hsu PP, Chen BP, Yuan S, Usami S, Shyy JY, Li YS, Chien S (2000) Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci U S A 97(17):9385–9389. https://doi.org/10.1073/pnas.170282597 · DOI · Paper page
  124. Fujita K, Horikawa I, Mondal AM, Jenkins LM, Appella E, Vojtesek B, Bourdon JC, Lane DP, Harris CC (2010) Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol 12(12):1205–1212. https://doi.org/10.1038/ncb2123 · DOI
  125. Stagno D’Alcontres M, Mendez-Bermudez A, Foxon JL, Royle NJ, Salomoni P (2007) Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA. J Cell Biol 179(5):855–867. https://doi.org/10.1083/jcb.200703020 · DOI
  126. Burke RM, Lighthouse JK, Quijada P, Dirkx RA Jr, Rosenberg A, Moravec CS, Alexis JD, Small EM (2018) Small proline-rich protein 2B drives stress-dependent p53 degradation and fibroblast proliferation in heart failure. Proc Natl Acad Sci USA 115(15):E3436–E3445. https://doi.org/10.1073/pnas.1717423115 · DOI
  127. Zhu F, Li Y, Zhang J, Piao C, Liu T, Li HH, Du J (2013) Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS One 8(9):e74535. https://doi.org/10.1371/journal.pone.0074535 · DOI · Paper page
  128. Chen SN, Lombardi R, Karmouch J, Tsai JY, Czernuszewicz G, Taylor MRG, Mestroni L, Coarfa C, Gurha P, Marian AJ (2019) DNA damage response/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A/C) mutations. Circ Res 124(6):856–873. https://doi.org/10.1161/CIRCRESAHA.118.314238 · DOI
  129. Ubil E, Duan J, Pillai IC, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, Vondriska TM, Stefani E, Deb A (2014) Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature 514(7524):585–590. https://doi.org/10.1038/nature13839 · DOI · Paper page
  130. Gudkov AV, Komarova EA (2010) Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol 2(7):a001180. https://doi.org/10.1101/cshperspect.a001180 · DOI
  131. Zhu J, Singh M, Selivanova G, Peuget S (2020) Pifithrin-alpha alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Sci Rep 10(1):1049. https://doi.org/10.1038/s41598-020-58051-1 · DOI
  132. Strom E, Sathe S, Komarov PG, Chernova OB, Pavlovska I, Shyshynova I, Bosykh DA, Burdelya LG, Macklis RM, Skaliter R, Komarova EA, Gudkov AV (2006) Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2(9):474–479. https://doi.org/10.1038/nchembio809 · DOI · Paper page
  133. Liu J, Mao W, Ding B, Liang CS (2008) ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol 295(5):H1956-1965. https://doi.org/10.1152/ajpheart.00407.2008 · DOI · Paper page
  134. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB (2009) Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemother Pharmacol 64(4):811–827. https://doi.org/10.1007/s00280-009-0932-x · DOI
  135. Liu P, Xu B, Cavalieri TA, Hock CE (2006) Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats. Shock 26(6):608–614. https://doi.org/10.1097/01.shk.0000232273.11225.af · DOI
  136. Liu P, Xu B, Cavalieri TA, Hock CE (2008) Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion. Shock 30(5):545–551. https://doi.org/10.1097/SHK.0b013e31816a192d · DOI · Paper page
  137. Mazelin L, Panthu B, Nicot AS, Belotti E, Tintignac L, Teixeira G, Zhang Q, Risson V, Baas D, Delaune E, Derumeaux G, Taillandier D, Ohlmann T, Ovize M, Gangloff YG, Schaeffer L (2016) mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis. J Mol Cell Cardiol 97:213–225. https://doi.org/10.1016/j.yjmcc.2016.04.011 · DOI
  138. Wang HJ, Lee EY, Han SJ, Kim SH, Lee BW, Ahn CW, Cha BS, Lee HC (2012) Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis. Metabolism 61(4):496–503. https://doi.org/10.1016/j.metabol.2011.09.005 · DOI
  139. Qi Z, He J, Su Y, He Q, Liu J, Yu L, Al-Attas O, Hussain T, Ding S, Ji L, Qian M (2011) Physical exercise regulates p53 activity targeting SCO2 and increases mitochondrial COX biogenesis in cardiac muscle with age. PLoS One 6(7):e21140. https://doi.org/10.1371/journal.pone.0021140 · DOI
  140. Zhang Y, Kohler K, Xu J, Lu D, Braun T, Schlitt A, Buerke M, Muller-Werdan U, Werdan K, Ebelt H (2011) Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. J Mol Cell Cardiol 50(3):471–478. https://doi.org/10.1016/j.yjmcc.2010.11.006 · DOI
  141. Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R (2010) Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 122(20):2039–2047. https://doi.org/10.1161/CIRCULATIONAHA.109.930222 · DOI · Paper page
  142. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112(4):544–552. https://doi.org/10.1161/CIRCULATIONAHA.104.531616 · DOI · Paper page
  143. Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R (2007) Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 43(4):429–436. https://doi.org/10.1016/j.yjmcc.2007.07.055 · DOI
  144. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ (1998) Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res 82(2):261–271. https://doi.org/10.1161/01.res.82.2.261 · DOI · Paper page
  145. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106(12):1543–1549. https://doi.org/10.1161/01.cir.0000028818.33488.7b · DOI · Paper page

Cited by

See all 137

Metadata

Authors
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L.
Venue
Cellular and Molecular Life Sciences
Published
2020-11-11
Volume
78
Issue
5
Pages
2001-2018
ISSN
  • 1420-682X
  • 1420-9071
Cited by
137
References
33
Language
en
Licence
Funders
National Key R&D Program of China (2016YFC0900903)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The regulatory roles of p53 in cardiovascular health and disease. https://app.cochat.ai/papers/10.1007/s00018-020-03694-6
The paper
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L. (2021). The regulatory roles of p53 in cardiovascular health and disease. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-020-03694-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.